Adherence and Safety of Ribociclib Plus Aromatase Inhibitors in Patients With Early Stage, HR+ and HER2- Breast Cancer
Clinical trial NCT07630948 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07630948
- Sponsor
- Institute of Oncology Ljubljana
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2026-09-01
- Primary completion
- 2029-09-01
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.